CS logo
small CS logo
Hôpital Henri Mondor

Creteil, France
General hospital in Créteil
1 Rue Gustave Eiffel, 94000 Créteil

About Hôpital Henri Mondor


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at Hôpital Henri Mondor


During the past decade, Hôpital Henri Mondor conducted 420 clinical trials. In the 10-year time frame, 420 clinical trials started and 84 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 162 clinical trials started and 51 clinical trials were completed. i.e. 31.5% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung Cancer
1999-07-01
2011-01-01
Completed
1,023
Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
1999-05-01
2017-07-19
Completed
475
Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Stage III or Stage IV Hodgkin's Lymphoma
2002-08-01
Completed
552
Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
2003-11-03
2025-12-01
Active, not recruiting
2,672
S0230 Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
2003-10-01
2016-09-01
Completed
257
Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer
2005-05-01
Completed
520
Safety and Efficacy of Avonex in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
2004-02-01
2006-02-01
Completed
67
Rituximab in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Follicular Non-Hodgkin's Lymphoma
2004-09-01
2022-05-01
Unknown status
600

Rows per page:

1–100 of 346

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Hôpital Henri Mondor" #1 sponsor was "Assistance Publique - Hôpitaux de Paris" with 133 trials, followed by "The Lymphoma Academic Research Organisation" with 40 trials sponsored, "UNICANCER" with 27 trials sponsored, "Celgene" with 20 trials sponsored and "Groupe Francophone des Myelodysplasies" with 20 trials sponsored. Other sponsors include 553 different institutions and companies that sponsored additional 231 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpital Henri Mondor" #1 collaborator was "Ministry of Health, France" with 16 trials as a collaborator, "National Cancer Institute, France" with 12 trials as a collaborator, "Roche Pharma AG" with 11 trials as a collaborator, "Novartis" with 10 trials as a collaborator and "Institut National de la Santé Et de la Recherche Médicale, France" with 9 trials as a collaborator. Other collaborators include 506 different institutions and companies that were collaborators in the rest 401 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Hôpital Henri Mondor


According to Clinical.Site data, the most researched conditions in "Hôpital Henri Mondor" are "Prostate Cancer" (18 trials), "Multiple Myeloma" (16 trials), "Myelodysplastic Syndromes" (12 trials), "Colorectal Cancer" (11 trials) and "Lymphoma" (11 trials). Many other conditions were trialed in "Hôpital Henri Mondor" in a lesser frequency.

Clinical Trials Intervention Types at Hôpital Henri Mondor


Most popular intervention types in "Hôpital Henri Mondor" are "Drug" (445 trials), "Other" (157 trials), "Device" (81 trials), "Procedure" (78 trials) and "Biological" (40 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (76 trials), "Rituximab" (25 trials), "Lenalidomide" (14 trials), "Gemcitabine" (12 trials) and "Cyclophosphamide" (11 trials). Other intervention names were less common.

Clinical Trials Genders at Hôpital Henri Mondor


The vast majority of trials in "Hôpital Henri Mondor" are 748 trials for "All" genders, 30 trials for "Male" genders and 16 trials for "Female" genders.

Clinical Trials Status at Hôpital Henri Mondor


Currently, there are 237 active trials in "Hôpital Henri Mondor". 19 are not yet recruiting, 153 are recruiting, 64 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 385 completed trials in Hôpital Henri Mondor, 1 suspended trials, and 75 terminated clinical trials to date.
Out of the total trials that were conducted in Hôpital Henri Mondor, 50 "Phase 1" clinical trials were conducted, 213 "Phase 2" clinical trials and 244 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 21 trials, and there were also 144 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status